Protia Inc. (KOSDAQ:303360)
4,940.00
-50.00 (-1.00%)
At close: Apr 29, 2026
Protia Market Cap
Protia has a market cap or net worth of 64.51 billion as of April 30, 2026. Its market cap has increased by 57.80% in one year.
Market Cap
64.51B
Enterprise Value
51.14B
Revenue
15.12B
Ranking
n/a
PE Ratio
14.44
Stock Price
4,940.00
Market Cap Chart
Since December 19, 2018, Protia's market cap has decreased from 78.41B to 64.51B, a decrease of -17.72%. That is a compound annual growth rate of -2.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 63.61B | -20.83% |
| Dec 30, 2025 | 80.35B | 127.74% |
| Dec 30, 2024 | 35.28B | -16.19% |
| Dec 28, 2023 | 42.10B | -45.57% |
| Dec 29, 2022 | 77.35B | 24.57% |
| Dec 30, 2021 | 62.09B | -38.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 465.08B |
| 3billion | 415.76B |
| Inventera | 195.46B |
| GENINUS | 173.20B |
| Cytogen | 128.73B |
| HLB Panagene | 100.26B |
| Green Cross Medical Science | 85.23B |
| Seoulin Bioscience | 57.20B |